Autolus Therapeutics plc (AUTL) Retained Earnings (Accumulated Deficit) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Autolus Therapeutics plc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2017 to 2024.
  • Autolus Therapeutics plc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$931 M, a 31.2% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$931 M -$221 M -31.2% Mar 31, 2024 10-Q 2024-05-17
Q4 2023 -$879 M -$208 M -31.1% Dec 31, 2023 10-Q 2024-05-17
Q3 2023 -$801 M -$158 M -24.6% Sep 30, 2023 10-K 2024-03-21
Q2 2023 -$756 M -$155 M -25.8% Jun 30, 2023 10-K 2024-03-21
Q1 2023 -$710 M -$152 M -27.1% Mar 31, 2023 10-K 2024-03-21
Q4 2022 -$670 M -$149 M -28.5% Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$643 M Sep 30, 2022 10-K 2024-03-21
Q2 2022 -$600 M Jun 30, 2022 10-K 2024-03-21
Q1 2022 -$558 M -$146 M -35.4% Mar 31, 2022 10-K 2024-03-21
Q4 2021 -$521 M -$142 M -37.5% Dec 31, 2021 20-F 2023-03-07
Q1 2021 -$413 M -$145 M -54.5% Mar 31, 2021 6-K 2021-05-06
Q4 2020 -$379 M -$142 M -59.9% Dec 31, 2020 20-F 2022-03-10
Q3 2020 -$336 M -$140 M -71.4% Sep 30, 2020 6-K 2020-11-05
Q2 2020 -$299 M -$130 M -77% Jun 30, 2020 6-K 2020-08-06
Q1 2020 -$267 M Mar 31, 2020 6-K 2020-05-07
Q4 2019 -$237 M -$124 M -109% Dec 31, 2019 20-F 2021-03-04
Q3 2019 -$196 M -$104 M -112% Sep 30, 2019 6-K 2019-11-07
Q2 2019 -$169 M Jun 30, 2019 6-K 2019-08-08
Q4 2018 -$113 M Dec 31, 2018 20-F 2020-03-03
Q3 2018 -$92.7 M -$44.8 M -93.4% Sep 30, 2018 20-F 2019-02-25
Q3 2017 -$47.9 M Sep 30, 2017 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.